Literature DB >> 11786315

Neurotensin: an endogenous psychostimulant?

Anne Bérod1, William Rostène.   

Abstract

The neuropeptide neurotensin has been shown to be closely related to central dopaminergic regulation. Although emphasis has been put on its possible neuroleptic-like effects, more recent data--in particular with the use of non-peptide neurotensin receptor antagonists--suggest instead a psychostimulant-like action of endogenous neurotensin. Such contradictory potential effects open an important debate on the possible therapeutic use of compounds related to neurotensin transmission.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11786315     DOI: 10.1016/s1471-4892(01)00127-8

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  5 in total

Review 1.  Functional implications of glutamatergic projections to the ventral tegmental area.

Authors:  Stefanie Geisler; Roy A Wise
Journal:  Rev Neurosci       Date:  2008       Impact factor: 4.353

2.  Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preference.

Authors:  Klara Felszeghy; José Manuel Espinosa; Hélène Scarna; Anne Bérod; William Rostène; Didier Pélaprat
Journal:  Neuropsychopharmacology       Date:  2007-03-14       Impact factor: 7.853

3.  Altered neurotensin mrna expression in mice lacking the dopamine transporter.

Authors:  C Roubert; C Spielewoy; P Soubrié; M Hamon; B Giros; C Betancur
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

4.  Diverse roles of neurotensin agonists in the central nervous system.

Authors:  Mona Boules; Zhimin Li; Kristin Smith; Paul Fredrickson; Elliott Richelson
Journal:  Front Endocrinol (Lausanne)       Date:  2013-03-22       Impact factor: 5.555

5.  Ventral Midbrain NTS1 Receptors Mediate Conditioned Reward Induced by the Neurotensin Analog, D-Tyr[11]neurotensin.

Authors:  Khalil Rouibi; Poulomee Bose; Pierre-Paul Rompré; Richard A Warren
Journal:  Front Neurosci       Date:  2015-12-22       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.